Evidence map›Paper›PMID 32928123›Full record

Trial reportBMC microbiology2020

Relative abundance of the Prevotella genus within the human gut microbiota of elderly volunteers determines the inter-individual responses to dietary supplementation with wheat bran arabinoxylan-oligosaccharides.

Wing Sun Faith Chung, Alan W Walker, Douwina Bosscher, Vicenta Garcia-Campayo, Josef Wagner, Julian Parkhill, Sylvia H Duncan, Harry J Flint

Registry-linked trialOpen access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in BMC microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02693782 (Effect of Wheat Bran Extract Containing Arabinoxylan Oligosaccharides, on the Gut Microbiota Composition and Well-being in Healthy Aging Subjects PhD Project), which is not on this map. Cited by 46 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02693782 nacompletednot on this map

Effect of Wheat Bran Extract Containing Arabinoxylan Oligosaccharides, on the Gut Microbiota Composition and Well-being in Healthy Aging Subjects PhD Project: New Targeted Prebiotic Approaches for Maintaining Human Health

TypeinterventionalSponsorUniversity of AberdeenRan2015 to 2016Enrolled21ConditionsHypercholesterolemia, Flatulence, Intestinal DiseasesArmsPlacebo, Fibre supplement
3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 1 synthesis or guideline pooled it, 88 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 3 countries.

Wing Sun Faith ChungGut Health Group, Rowett Institute, University of Aberdeen, Foresterhill, Aberdeen, Scotland, AB25 2ZD, UK.
Alan W WalkerGut Health Group, Rowett Institute, University of Aberdeen, Foresterhill, Aberdeen, Scotland, AB25 2ZD, UK.
Douwina BosscherCargill R&D Centre Europe BVBA, Havenstraat 84, B-1800, Vilvoorde, Belgium.
Vicenta Garcia-CampayoCargill, Incorporated, PO Box 9300, Minneapolis, MN, 55440-9300, USA.
Josef WagnerPathogen Genomics Group, Wellcome Sanger Institute, Hinxton, Cambridgeshire, CB10 1SA, UK.
Julian ParkhillDepartment of Veterinary Medicine, University of Cambridge, Madingley Road, Cambridge, CB3 0ES, UK.
Sylvia H DuncanGut Health Group, Rowett Institute, University of Aberdeen, Foresterhill, Aberdeen, Scotland, AB25 2ZD, UK. sylvia.duncan@abdn.ac.uk.ORCID 0000-0002-4903-0978
Harry J FlintGut Health Group, Rowett Institute, University of Aberdeen, Foresterhill, Aberdeen, Scotland, AB25 2ZD, UK.
University of Aberdeen · GBCargill (Belgium) · BECargill (United States) · USUniversity of Cambridge · GBWellcome Sanger Institute · GB

Funding

Biotechnology and Biological Sciences Research Council A08456Wellcome TrustWellcome Trust WT098051
6 · The paper itself

Abstract

backgroundThe human colon is colonised by a dense microbial community whose species composition and metabolism are linked to health and disease. The main energy sources for colonic bacteria are dietary polysaccharides and oligosaccharides. These play a major role in modulating gut microbial composition and metabolism, which in turn can impact on health outcomes.

resultsWe investigated the influence of wheat bran arabinoxylan oligosaccharides (AXOS) and maltodextrin supplements in modulating the composition of the colonic microbiota and metabolites in healthy adults over the age of 60. Male and female volunteers, (n = 21, mean BMI 25.2 ± 0.7 kg/m

conclusionsThe wheat bran AXOS supplementation was bifidogenic and resulted in changes in human gut microbiota composition that depended on the initial microbiota profile, specifically the presence or absence of Prevotella spp. as a major component of the microbiota. Our data therefore suggest that initial profiling of individuals through gut microbiota analysis should be considered important when contemplating nutritional interventions that rely on prebiotics.

trial registrationClinical trial registration number: NCT02693782 . Registered 29 February 2016 - Retrospectively registered, https://clinicaltrials.gov/ct2/show/NCT02693782?term=NCT02693782&rank=1.

Indexed as

Dietary FiberAgedDietary SupplementsDouble-Blind MethodFatty Acids, VolatileFecesFemaleGastrointestinal MicrobiomeHumansLeukocyte L1 Antigen ComplexLipidsMaleMiddle AgedOligosaccharidesPolysaccharidesPrebioticsarabinoxylanDietary FiberFatty Acids, VolatileLeukocyte L1 Antigen ComplexLipidsmaltodextrinOligosaccharidesPolysaccharidesPrebioticsXylansArabinoxylan oligosaccharides (AXOS)BacteroidesBifidobacteriaButyrateDiversityGut microbiotaPrevotellaPropionateShort chain fatty acidsWheatbran extract

Identifiers

PMID32928123
PMCPMC7490872
OpenAlexW3084682371

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.